Submit
Search
Submit
Menu

  • Information

  • References

  • Contents

  • [1]Swinney, D. C.: The role of binding kinetics in therapeutically useful drug action. Curr Opin Drug Discov Devel, 12, 31-9 (2009)

  • [2]Swinney, D. C., B. A. Haubrich, I. V. Liefde & G. Vauquelin: The role of binding kinetics in GPCR drug discovery. Curr Top Med Chem (2015)

  • [3]Vauquelin, G.: On the ‘micro’-pharmacodynamic and pharmacokinetic mechanisms that contribute to long-lasting drug action. Expert Opin Drug Discov1-14 (2015)

  • [4]Zhang, R.: Pharmacodynamics: Which trails are your drugs taking? Nat Chem Biol, 11, 382-3 (2015)

  • [5]Zhang, R. & F. Monsma: Binding kinetics and mechanism of action: toward the discovery and development of better and best in class drugs. Expert Opin Drug Discov, 5, 1023-9 (2010)

  • [6]Copeland, R. A.: The dynamics of drug-target interactions: drug-target residence time and its impact on efficacy and safety. Expert Opin Drug Discov, 5, 305-10 (2010)

  • [7]Copeland, R. A.: Conformational adaptation in drug-target interactions and residence time. Future Med Chem, 3, 1491-501 (2011)

  • [8]Copeland, R. A.: Drug-target interactions: Stay tuned. Nat Chem Biol, 11, 451-2 (2015)

  • [9]Copeland, R. A., D. L. Pompliano & T. D. Meek: Drug-target residence time and its implications for lead optimization. Nat Rev Drug Discov, 5, 730-9 (2006)

  • [10]Dahl, G. & T. Akerud: Pharmacokinetics and the drug-target residence time concept. Drug Discov Today, 18, 697-707 (2013)

  • [11]Lu, H. & P. J. Tonge: Drug-target residence time: critical information for lead optimization. Curr Opin Chem Biol, 14, 467-74 (2010)

  • [12]Tummino, P. J. & R. A. Copeland: Residence time of receptor-ligand complexes and its effect on biological function. Biochemistry, 47, 5481-92 (2008)

  • [13]Zhang, R. & F. Monsma: The importance of drug-target residence time. Curr Opin Drug Discov Devel, 12, 488-96 (2009)

  • [14]Apgar, J. F., D. K. Witmer, F. M. White & B. Tidor: Sloppy models, parameter uncertainty, and the role of experimental design. Mol Biosyst, 6, 1890-900 (2010)

  • [15]Chachra, R., M. K. Transtrum & J. P. Sethna: Comment on “Sloppy models, parameter uncertainty, and the role of experimental design”. Mol Biosyst, 7, 2522; author reply 2523-4 (2011)

  • [16]Daniels, B. C., Y. J. Chen, J. P. Sethna, R. N. Gutenkunst & C. R. Myers: Sloppiness, robustness, and evolvability in systems biology. Curr Opin Biotechnol, 19, 389-95 (2008)

  • [17]Gutenkunst, R. N., J. J. Waterfall, F. P. Casey, K. S. Brown, C. R. Myers & J. P. Sethna: Universally sloppy parameter sensitivities in systems biology models. PLoS Comput Biol, 3, 1871-78 (2007)

  • [18]Hagen, D. R., J. F. Apgar, D. K. Witmer, F. M. White & B. Tidor: Reply to Comment on “Sloppy models, parameter uncertainty, and the role of experimental design”. Mol Biosyst, 7, 2523-2524 (2011)

  • [19]Bairy, S. & C. F. Wong: Influence of kinetics of drug binding on EGFR signaling: a comparative study of three EGFR signaling pathway models. Proteins, 79, 2491-504 (2011)

  • [20]Goyal, M., M. Rizzo, F. Schumacher & C. F. Wong: Beyond thermodynamics: drug binding kinetics could influence epidermal growth factor signaling. J Med Chem, 52, 5582-5 (2009)

  • [21]Randhawa, V., P. Sharma, S. Bhushan & G. Bagler: Identification of key nodes of type 2 diabetes mellitus protein interactome and study of their interactions with phloridzin. Omics, 17, 302-17 (2013)

  • [22]Wong, C. F. & S. Bairy: Drug design for protein kinases and phosphatases: flexible-receptor docking, binding affinity and specificity, and drug-binding kinetics. Curr Pharm Des, 19, 4739-54 (2013)

  • [23]Danielson, U. H.: Fragment library screening and lead characterization using SPR biosensors. Curr Top Med Chem, 9, 1725-35 (2009)

  • [24]Olaru, A., C. Bala, N. Jaffrezic-Renault & H. Y. Aboul-Enein: Surface plasmon resonance (SPR) biosensors in pharmaceutical analysis. Crit Rev Anal Chem, 45, 97-105 (2015)

  • [25]Kodoyianni, V.: Label-free analysis of biomolecular interactions using SPR imaging. Biotechniques, 50, 32-40 (2011)

  • [26]Lausted, C., Z. Hu, L. Hood & C. T. Campbell: SPR imaging for high throughput, label-free interaction analysis. Comb Chem High Throughput Screen, 12, 741-51 (2009)

  • [27]Linman, M. J., A. Abbas & Q. Cheng: Interface design and multiplexed analysis with surface plasmon resonance (SPR) spectroscopy and SPR imaging. Analyst, 135, 2759-67 (2010)

  • [28]Yanase, Y., T. Hiragun, T. Yanase, T. Kawaguchi, K. Ishii & M. Hide: Application of SPR imaging sensor for detection of individual living cell reactions and clinical diagnosis of type I allergy. Allergol Int, 62, 163-9 (2013)

  • [29]Concepcion, J., K. Witte, C. Wartchow, S. Choo, D. Yao, H. Persson, J. Wei, P. Li, B. Heidecker, W. Ma, R. Varma, L. S. Zhao, D. Perillat, G. Carricato, M. Recknor, K. Du, H. Ho, T. Ellis, J. Gamez, M. Howes, J. Phi-Wilson, S. Lockard, R. Zuk & H. Tan: Label-free detection of biomolecular interactions using BioLayer interferometry for kinetic characterization. Comb Chem High Throughput Screen, 12, 791-800 (2009)

  • [30]Morcos, E. F., A. Kussrow, C. Enders & D. Bornhop: Free-solution interaction assay of carbonic anhydrase to its inhibitors using back-scattering interferometry. Electrophoresis, 31, 3691-5 (2010)

  • [31]Haddad, G. L., S. C. Young, N. D. Heindel, D. J. Bornhop & R. A. Flowers, 2nd: Back-scattering interferometry: an ultrasensitive method for the unperturbed detection of acetylcholinesterase-inhibitor interactions. Angew Chem Int Ed Engl, 51, 11126-30 (2012)

  • [32]Jepsen, S. T., T. M. Jorgensen, W. Zong, T. Trydal, S. R. Kristensen & H. S. Sorensen: Evaluation of back scatter interferometry, a method for detecting protein binding in solution. Analyst, 140, 895-901 (2015)

  • [33]Daghestani, H. N. & B. W. Day: Theory and applications of surface plasmon resonance, resonant mirror, resonant waveguide grating, and dual polarization interferometry biosensors. Sensors (Basel), 10, 9630-46 (2010)

  • [34]Liang, W., S. Wang, F. Festa, P. Wiktor, W. Wang, M. Magee, J. LaBaer & N. Tao: Measurement of small molecule binding kinetics on a protein microarray by plasmonic-based electrochemical impedance imaging. Anal Chem, 86, 9860-5 (2014)

  • [35]Knezevic, J., A. Langer, P. A. Hampel, W. Kaiser, R. Strasser & U. Rant: Quantitation of affinity, avidity, and binding kinetics of protein analytes with a dynamically switchable biosurface. J Am Chem Soc, 134, 15225-8 (2012)

  • [36]Langer, A., P. A. Hampel, W. Kaiser, J. Knezevic, T. Welte, V. Villa, M. Maruyama, M. Svejda, S. Jahner, F. Fischer, R. Strasser & U. Rant: Protein analysis by time-resolved measurements with an electro-switchable DNA chip. Nat Commun, 4, 2099 (2013)

  • [37]Langer, A., W. Kaiser, M. Svejda, P. Schwertler & U. Rant: Molecular dynamics of DNA-protein conjugates on electrified surfaces: solutions to the drift-diffusion equation. J Phys Chem B, 118, 597-607 (2014)

  • [38]Langer, A., M. Schraml, R. Strasser, H. Daub, T. Myers, D. Heindl & U. Rant: Polymerase/DNA interactions and enzymatic activity: multi-parameter analysis with electro-switchable biosurfaces. Sci Rep, 5, 12066 (2015)

  • [39]Campagnola, P.: Second harmonic generation imaging microscopy: applications to diseases diagnostics. Anal Chem, 83, 3224-31 (2011)

  • [40]Schiele, F., P. Ayaz & A. Fernandez-Montalvan: Auniversal homogeneous assay for high-throughput determination of binding kinetics. Anal Biochem, 468C, 42-49 (2015)

  • [41]Zhang, R. & W. T. Windsor: In vitro kinetic profiling of hepatitis C virus NS3 protease inhibitors by progress curve analysis. Methods Mol Biol, 1030, 59-79 (2013)

  • [42]Bao, J., S. M. Krylova, L. T. Cherney, J. C. Le Blanc, P. Pribil, P. E. Johnson, D. J. Wilson & S. N. Krylov: Pre-equilibration kinetic size-exclusion chromatography with mass spectrometry detection (peKSEC-MS) for label-free solution-based kinetic analysis of protein-small molecule interactions. Analyst, 140, 990-4 (2015)

  • [43]Bao, J., S. M. Krylova, L. T. Cherney, J. C. LeBlanc, P. Pribil, P. E. Johnson, D. J. Wilson & S. N. Krylov: Kinetic size-exclusion chromatography with mass spectrometry detection: an approach for solution-based label-free kinetic analysis of protein-small molecule interactions. Anal Chem, 86, 10016-20 (2014)

  • [44]Copeland, R. A., A. Basavapathruni, M. Moyer & M. P. Scott: Impact of enzyme concentration and residence time on apparent activity recovery in jump dilution analysis. Anal Biochem, 416, 206-10 (2011)

  • [45]Demarse, N. A., M. C. Killian, L. D. Hansen & C. F. Quinn: Determining enzyme kinetics via isothermal titration calorimetry. Methods Mol Biol, 978, 21-30 (2013)

  • [46]Maximova, K. & J. Trylska: Kinetics of trypsin-catalyzed hydrolysis determined by isothermal titration calorimetry. Anal Biochem, 486, 24-34 (2015)

  • [47]Transtrum, M. K., L. D. Hansen & C. Quinn: Enzyme kinetics determined by single-injection isothermal titration calorimetry. Methods, 76, 194-200 (2015)

  • [48]Burzomato, V., M. Beato, P. J. Groot-Kormelink, D. Colquhoun & L. G. Sivilotti: Single-channel behavior of heteromeric alpha1beta glycine receptors: an attempt to detect a conformational change before the channel opens. J Neurosci, 24, 10924-40 (2004)

  • [49]Finzi, L. & D. D. Dunlap: Single-molecule approaches to probe the structure, kinetics, and thermodynamics of nucleoprotein complexes that regulate transcription. J Biol Chem, 285, 18973-8 (2010)

  • [50]Li, G. W. & J. Elf: Single molecule approaches to transcription factor kinetics in living cells. FEBS Lett, 583, 3979-83 (2009)

  • [51]Qian, H. & L. M. Bishop: The chemical master equation approach to nonequilibrium steady-state of open biochemical systems: linear single-molecule enzyme kinetics and nonlinear biochemical reaction networks. Int J Mol Sci, 11, 3472-500 (2010)

  • [52]Shi, J., J. Dertouzos, A. Gafni & D. Steel: Application of single-molecule spectroscopy in studying enzyme kinetics and mechanism. Methods Enzymol, 450, 129-57 (2008)

  • [53]van Oijen, A. M.: Single-molecule approaches to characterizing kinetics of biomolecular interactions. Curr Opin Biotechnol, 22, 75-80 (2010)

  • [54]Dupont, P. & J. Warwick: Kinetic modelling in small animal imaging with PET. Methods, 48, 98-103 (2009)

  • [55]Ikoma, Y., H. Watabe, M. Shidahara, M. Naganawa & Y. Kimura: PET kinetic analysis: error consideration of quantitative analysis in dynamic studies. Ann Nucl Med, 22, 1-11 (2008)

  • [56]Kimura, Y., M. Naganawa, M. Shidahara, Y. Ikoma & H. Watabe: PET kinetic analysis--pitfalls and a solution for the Logan plot. Ann Nucl Med, 21, 1-8 (2007)

  • [57]Li, F., J. T. Joergensen, A. E. Hansen & A. Kjaer: Kinetic modeling in PET imaging of hypoxia. Am J Nucl Med Mol Imaging, 4, 490-506 (2014)

  • [58]Shidahara, M., Y. Ikoma, J. Kershaw, Y. Kimura, M. Naganawa & H. Watabe: PET kinetic analysis: wavelet denoising of dynamic PET data with application to parametric imaging. Ann Nucl Med, 21, 379-86 (2007)

  • [59]Wang, G. & J. Qi: Direct estimation of kinetic parametric images for dynamic PET. Theranostics, 3, 802-15 (2013)

  • [60]Watabe, H., Y. Ikoma, Y. Kimura, M. Naganawa & M. Shidahara: PET kinetic analysis--compartmental model. Ann Nucl Med, 20, 583-8 (2006)

  • [61]Chance, B.: The accelerated flow method for measuring rapid reactions. Journal of the Franklin Institute, 229, 455-76, 613–40, 737-66 (1940)

  • [62]Chance, B., E. N. Harvey, F. Johnson & G. Millikan: The Kinetics of Bioluminescent Flashes: AStudy of Consecutive Reactions. Journal of Cellular and Comparative Physiology 15, 195-215 (1940)

  • [63]Gibson, Q. H. & L. Milnes: Apparatus for rapid and sensitive spectrophotometry. The Biochemical journal, 91, 161-71 (1964)

  • [64]Johnson, K. A.: Transient-State Kinetic Analyis of Enzyme Reaction Pathways. In: The Enzymes. Ed: D. S. Sigman. Academic Press, Inc., San Diego, CA (1992)

  • [65]Martin, S. R. & M. J. Schilstra: Rapid Mixing Kinetic Techniques. In: Protein-Ligand Interactions: Methods and Applications. 2nd ed. Eds: M. A. Williams&T. Daviter. Humana Press, London, UK (2013)

  • [66]Wang, R.-Y.: Rapid Scan, Stopped-Flow Kinetics. In: Applications of Physical Methods to Inorganic and Bioorganic Chemistry. Eds: R. A. Scott&C. M. Lukehart. John Wiley & Sons Ltd, Hoboken, NJ (2007)

  • [67]Dobson, C. M. & P. J. Hore: Kinetic studies of protein folding using NMR spectroscopy. Nature structural biology, 5, 504-7 (1998)

  • [68]Hoeltzli, S. D. & C. Frieden: Refolding of (6-19F)tryptophan-labeled Escherichia coli dihydrofolate reductase in the presence of ligand: a stopped-flow NMR spectroscopy study. Biochemistry, 37, 387-98 (1998)

  • [69]Sienkiewicz, A., A. M. da Costa Ferreira, B. Danner & C. P. Scholes: Dielectric resonator-based flow and stopped-flow EPR with rapid field scanning: Amethodology for increasing kinetic information. J Magn Reson, 136, 137-42 (1999)

  • [70]Grillo, I.: Applications of stopped-flow in SAXS and SANS. Curr Opin Colloid In, 14, 402-8 (2009)

  • [71]Hubert, J. F., L. Duchesne, C. Delamarche, A. Vaysse, H. Gueune & C. Raguenes-Nicol: Pore selectivity analysis of an aquaglyceroporin by stopped-flow spectrophotometry on bacterial cell suspensions. Biol Cell, 97, 675-86 (2005)

  • [72]de Mol, N. J. & M. J. E. Fischer: Surface Plasmon Resonance: Methods and Protocols. Humana Press, NewYork (2010)

  • [73]Fischer, M., A. P. Leech & R. E. Hubbard: Comparative assessment of different histidine-tags for immobilization of protein onto surface plasmon resonance sensorchips. Anal Chem, 83, 1800-7 (2011)

  • [74]Chapman-Smith, A. & J. E. Cronan, Jr.: In vivo enzymatic protein biotinylation. Biomol Eng, 16, 119-25 (1999)

  • [75]MacDonald, J. I., H. K. Munch, T. Moore & M. B. Francis: One-step site-specific modification of native proteins with 2-pyridinecarboxyaldehydes. Nat Chem Biol, 11, 326-31 (2015)

  • [76]Zhang, R. & F. Monsma: Fluorescence-based thermal shift assays. Curr Opin Drug Discov Devel, 13, 389-402 (2010)

  • [77]Schuck, P. & H. Zhao: The role of mass transport limitation and surface heterogeneity in the biophysical characterization of macromolecular binding processes by SPR biosensing. Methods Mol Biol, 627, 15-54 (2010)

  • [78]Onell, A. & K. Andersson: Kinetic determinations of molecular interactions using Biacore--minimum data requirements for efficient experimental design. J Mol Recognit, 18, 307-17 (2005)

  • [79]Johnson, K. A.: Fitting enzyme kinetic data with KinTek Global Kinetic Explorer. Methods Enzymol, 467, 601-26 (2009)

  • [80]Hulme, E. C. & M. A. Trevethick: Ligand binding assays at equilibrium: validation and interpretation. Br J Pharmacol, 161, 1219-37 (2010)

  • [81]Motulsky, H. J. & R. R. Neubig: Analyzing binding data. Curr Protoc Neurosci, Chapter7, Unit75 (2010)

  • [82]Weiland, G. A. & P. B. Molinoff: Quantitative analysis of drug-receptor interactions: I. Determination of kinetic and equilibrium properties. Life Sci, 29, 313-30 (1981)

  • [83]Garcia-Calvo, M., H. G. Knaus, O. B. McManus, K. M. Giangiacomo, G. J. Kaczorowski & M. L. Garcia: Purification and reconstitution of the high-conductance, calcium-activated potassium channel from tracheal smooth muscle. J Biol Chem, 269, 676-82 (1994)

  • [84]Garcia-Calvo, M., J. Lisnock, H. G. Bull, B. E. Hawes, D. A. Burnett, M. P. Braun, J. H. Crona, H. R. Davis, Jr., D. C. Dean, P. A. Detmers, M. P. Graziano, M. Hughes, D. E. Macintyre, A. Ogawa, A. O’Neill K, S. P. Iyer, D. E. Shevell, M. M. Smith, Y. S. Tang, A. M. Makarewicz, F. Ujjainwalla, S. W. Altmann, K. T. Chapman & N. A. Thornberry: The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1). Proc Natl Acad Sci U S A, 102, 8132-7 (2005)

  • [85]Shrikhande, A., C. Courtney, D. Smith, M. Melch, M. McConkey, J. Bergeron & S. K. Wong: Fully automated radioligand binding filtration assay for membrane-bound receptors. Biotechniques, 33, 932-7 (2002)

  • [86]Liu, J., A. Zacco, T. M. Piser & C. W. Scott: Microplate gel-filtration method for radioligand-binding assays. Anal Biochem, 308, 127-33 (2002)

  • [87]Berry, J., M. Price-Jones & B. Killian: Use of scintillation proximity assay to measure radioligand binding to immobilized receptors without separation of bound from free ligand. Methods Mol Biol, 897, 79-94 (2012)

  • [88]Glickman, J. F., A. Schmid & S. Ferrand: Scintillation proximity assays in high-throughput screening. Assay Drug Dev Technol, 6, 433-55 (2008)

  • [89]Contreras, M. L., B. B. Wolfe & P. B. Molinoff: Kinetic analysis of the interactions of agonists and antagonists with beta adrenergic receptors. J Pharmacol Exp Ther, 239, 136-43 (1986)

  • [90]Sykes, D. A., M. R. Dowling & S. J. Charlton: Measuring receptor target coverage: a radioligand competition binding protocol for assessing the association and dissociation rates of unlabeled compounds. Curr Protoc Pharmacol, Chapter9, Unit914 (2010)

  • [91]Motulsky, H. J. & L. C. Mahan: The kinetics of competitive radioligand binding predicted by the law of mass action. Mol Pharmacol, 25, 1-9 (1984)

  • [92]Packeu, A., M. Wennerberg, A. Balendran & G. Vauquelin: Estimation of the dissociation rate of unlabelled ligand-receptor complexes by a ‘two-step’ competition binding approach. Br J Pharmacol, 161, 1311-28 (2010)

  • [93]Vauquelin, G.: Determination of drug–receptor residence times by radioligand binding and functional assays: experimental strategies and physiological relevance. Med. Chem. Commun., 3, 645-651 (2012)

  • [94]Vauquelin, G. & I. Van Liefde: Radioligand dissociation measurements: potential interference of rebinding and allosteric mechanisms and physiological relevance of the biological model systems. Expert Opin Drug Discov, 7, 583-95 (2012)

  • [95]Vauquelin, G., D. Hall & S. J. Charlton: ‘Partial’ competition of heterobivalent ligand binding may be mistaken for allosteric interactions: a comparison of different target interaction models. Br J Pharmacol, 172, 2300-15 (2015)

  • [96]Xu, W., J. D. Podoll, X. Dong, A. Tumber, U. Oppermann & X. Wang: Quantitative analysis of histone demethylase probes using fluorescence polarization. J Med Chem, 56, 5198-202 (2013)

  • [97]Zhang, J., W. Z. Shou, M. Vath, K. Kieltyka, J. Maloney, L. Elvebak, J. Stewart, J. Herbst & H. N. Weller: An integrated bioanalytical platform for supporting high-throughput serum protein binding screening. Rapid Commun Mass Spectrom, 24, 3593-601 (2010)

  • [98]Jonker, N., J. Kool, H. Irth & W. M. Niessen: Recent developments in protein-ligand affinity mass spectrometry. Anal Bioanal Chem, 399, 2669-81 (2011)

  • [99]Liu, Y. H., L. Ramanathan, B. Malcolm, G. Njoroge, T. Y. Chan & B. N. Pramanik: Screening and rank ordering of reversible mechanism-based inhibitors of hepatitis C virus NS3 protease using electrospray ionization mass spectrometry. J Mass Spectrom, 46, 764-71 (2011)

  • [100]Need, A. B., J. H. McKinzie, C. H. Mitch, M. A. Statnick & L. A. Phebus: In vivo rat brain opioid receptor binding of LY255582 assessed with a novel method using LC/MS/MS and the administration of three tracers simultaneously. Life Sci, 81, 1389-96 (2007)

  • [101]Hofner, G. & K. T. Wanner: Competitive binding assays made easy with a native marker and mass spectrometric quantification. Angew Chem Int Ed Engl, 42, 5235-7 (2003)

  • [102]Niessen, K. V., G. Hofner & K. T. Wanner: Competitive MS binding assays for dopamine D2 receptors employing spiperone as a native marker. Chembiochem, 6, 1769-75 (2005)

  • [103]Zepperitz, C., G. Hofner & K. T. Wanner: MS-binding assays: kinetic, saturation, and competitive experiments based on quantitation of bound marker as exemplified by the GABA transporter mGAT1. ChemMedChem, 1, 208-17 (2006)

  • [104]Zepperitz, C., G. Hofner & K. T. Wanner: Expanding the scope of MS binding assays to low-affinity markers as exemplified for mGAT1. Anal Bioanal Chem, 391, 309-16 (2008)

  • [105]Hofner, G., D. Merkel & K. T. Wanner: MS binding assays-with MALDI toward high throughput. ChemMedChem, 4, 1523-8 (2009)

  • [106]Hofner, G. & K. T. Wanner: Using short columns to speed up LC-MS quantification in MS binding assays. J Chromatogr B Analyt Technol Biomed Life Sci, 878, 1356-64 (2010)

  • [107]Grimm, S. H., G. Hofner & K. T. Wanner: MS Binding Assays for the Three Monoamine Transporters Using the Triple Reuptake Inhibitor (1R, 3S)-Indatraline as Native Marker. Chem Med Chem, 10, 1027-39 (2015)

  • [108]de Jong, L. A., C. M. Jeronimus-Stratingh & T. I. Cremers: Development of a multiplex non-radioactive receptor assay: the benzodiazepine receptor, the serotonin transporter and the beta-adrenergic receptor. Rapid Commun Mass Spectrom, 21, 567-72 (2007)

  • [109]Li, C. M., Y. Lu, S. Ahn, R. Narayanan, D. D. Miller & J. T. Dalton: Competitive mass spectrometry binding assay for characterization of three binding sites of tubulin. J Mass Spectrom, 45, 1160-6 (2010)

  • [110]Mulabagal, V. & A. I. Calderon: Development of an ultrafiltration-liquid chromatography/mass spectrometry (UF-LC/MS) based ligand-binding assay and an LC/MS based functional assay for Mycobacterium tuberculosis shikimate kinase. Anal Chem, 82, 3616-21 (2010)

  • [111]Mulabagal, V. & A. I. Calderon: Development of binding assays to screen ligands for Plasmodium falciparum thioredoxin and glutathione reductases by ultrafiltration and liquid chromatography/mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci, 878, 987-93 (2010)

  • [112]Bradshaw, J. M., J. M. McFarland, V. O. Paavilainen, A. Bisconte, D. Tam, V. T. Phan, S. Romanov, D. Finkle, J. Shu, V. Patel, T. Ton, X. Li, D. G. Loughhead, P. A. Nunn, D. E. Karr, M. E. Gerritsen, J. O. Funk, T. D. Owens, E. Verner, K. A. Brameld, R. J. Hill, D. M. Goldstein & J. Taunton: Prolonged and tunable residence time using reversible covalent kinase inhibitors. Nat Chem Biol, 11, 525-31 (2015)

  • [113]Louvel, J., D. Guo, M. Agliardi, T. A. Mocking, R. Kars, T. P. Pham, L. Xia, H. de Vries, J. Brussee, L. H. Heitman & A. P. Ijzerman: Agonists for the adenosine A1 receptor with tunable residence time. ACase for nonribose 4-amino-6-aryl-5-cyano-2-thiopyrimidines. J Med Chem, 57, 3213-22 (2014)

  • [114]Ramsey, S. J., N. J. Attkins, R. Fish & P. H. van der Graaf: Quantitative pharmacological analysis of antagonist binding kinetics at CRF1 receptors in vitro and in vivo. Br J Pharmacol, 164, 992-1007 (2011)

  • [115]Walkup, G. K., Z. You, P. L. Ross, E. K. Allen, F. Daryaee, M. R. Hale, J. O’Donnell, D. E. Ehmann, V. J. Schuck, E. T. Buurman, A. L. Choy, L. Hajec, K. Murphy-Benenato, V. Marone, S. A. Patey, L. A. Grosser, M. Johnstone, S. G. Walker, P. J. Tonge & S. L. Fisher: Translating slow-binding inhibition kinetics into cellular and in vivo effects. Nat Chem Biol, 11, 416-23 (2015)

Article Metrics

  • Information

  • Download

  • Contents

Frontiers in Bioscience-Scholar (FBS) is published by IMR Press from Volume 13 Issue 1 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with Frontiers in Bioscience.

1 Jun 2016Review

Moderate to high throughput in vitro binding kinetics for drug discovery

Rumin Zhang 1,*, Christopher M. Barbieri 1, Margarita Garcia-Calvo 1, Robert W. Myers 1, David McLaren 1, Michael Kavana 1
Affiliation
Article Info

1 In vitro Pharmacology, Merck Research Laboratories, 2015 Galloping Hill Road, Kenilworth, New Jersey, USA

*Author to whom correspondence should be addressed.

 

Abstract

This review provides a concise summary for state of the art, moderate to high throughput in vitro technologies being employed to studydrug-target binding kinetics. These technologies cover a wide kinetic timescale spanning up to nine orders of magnitude from milliseconds to days. Automated stopped flow measurestransient and (pre)steady state kinetics from milliseconds to seconds. For seconds to hours timescale kinetics we discuss surface plasmon resonance-based biosensor,global progress curve analysis for high throughput kinetic profiling of enzyme inhibitors and activators, and filtration plate-based radioligand or fluorescentbinding assays for receptor binding kinetics. Jump dilution after pre-incubation is the preferred method for very slow kinetics lasting for days. The basic principles,best practices and simulated data for these technologies are described. Finally, the application of a universal label-free technology, liquid chromatography coupledtandem mass spectrometry (LC/MS/MS), is briefly reviewed. Select literature references are highlighted for in-depth understanding. A new reality is dawning whereinbinding kinetics is an integral and routine part of mechanism of action elucidation and translational, quantitative pharmacology for drug discovery.

Keywords

  • Binding Kinetics
  • Bk
  • Stopped Flow
  • Surface Plasma Resonance
  • SPR
  • Global Progress Curve Analysis
  • GPCA
  • Radioligand Binding
  • Jump Dilution
  • Review

References